BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 73 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $286,000 | -68.6% | 9,438 | -69.9% | 0.00% | -66.7% |
| Q2 2021 | $911,000 | +90.2% | 31,351 | +202.5% | 0.00% | -25.0% |
| Q4 2020 | $479,000 | +48.8% | 10,365 | -28.1% | 0.00% | -50.0% |
| Q1 2020 | $322,000 | -4.7% | 14,419 | -37.6% | 0.01% | +300.0% |
| Q4 2019 | $338,000 | +35.2% | 23,118 | -35.0% | 0.00% | 0.0% |
| Q3 2019 | $250,000 | -29.0% | 35,548 | +10.5% | 0.00% | -33.3% |
| Q2 2019 | $352,000 | +147.9% | 32,162 | +73.8% | 0.00% | +50.0% |
| Q3 2018 | $142,000 | – | 18,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |